A Comprehensive Guide to Endotoxin Testing: Methods, Sample Preparation & Results Interpretation

Reliable bacterial endotoxin testing (BET) depends on more than assay sensitivity. Sample preparation, contamination control, product-related interference, reagent performance, and result interpretation all influence the validity of the final result.

This guide explains how endotoxin testing works, how to prepare samples, how to identify common sources of assay interference, and how to evaluate assay results.

What Is Endotoxin Testing? Methods, Principles

Endotoxin testing, also known as bacterial endotoxin testing (BET), detects lipopolysaccharides (LPS) from Gram-negative bacteria, such as E. coli and Salmonella. Because endotoxins can persist after bacteria are killed and trigger inflammatory responses, testing is essential for applicable pharmaceuticals, biologics, and medical devices. Common methods include Limulus Amebocyte Lysate (LAL) assays, such as gel-clot, turbidimetric, and chromogenic methods, and recombinant assays, including recombinant Factor C (rFC) and recombinant cascade reagents (rCR). While LAL assays use horseshoe crab-derived lysate, recombinant methods use engineered proteins. The rFC assay generates a fluorescent signal in response to endotoxin, while rCR typically uses a recombinant enzymatic cascade with chromogenic detection. Unlike LAL formats containing the Factor G pathway, single-factor rFC assays avoid Factor G-mediated β-glucan interference. Regardless of the method, product-specific matrix effects and assay suitability must be evaluated to ensure reliable results.

rFC Endotoxin Detection: A Sustainable Alternative

The rFC assay uses recombinant Factor C to detect endotoxins through fluorescence. As an animal-free method without Factor G, it avoids Factor G-mediated β-glucan interference associated with certain LAL assays.

How to Prepare for Endotoxin Testing: Samples, Equipment, and Environment

In practical testing, the endotoxin concentration in samples may be too high or too low, exceeding the linear range of the detection method. If the concentration is too high, signal saturation may occur, making it impossible to determine the true endotoxin level. If too low, the signal may be faint and susceptible to background noise interference, also compromising result accuracy. Moreover, matrix effects—interferences caused by other components in the sample—can affect the test. Proper dilution brings the endotoxin concentration within the assay’s linear range and reduces matrix effects, thereby improving the accuracy and reliability of the test results.

• Environmental Requirements

To avoid outsourced contamination from external endotoxins, testing should be done in a clean environment, ideally in a dedicated clean workstation. Regular cleaning, disinfection, and air purification are necessary to maintain a clean workspace. The lab temperature should be kept between 18–25°C, and unnecessary movement should be minimized during testing to avoid outside interference.

• Instrument and Reagent Preparation

Instruments: Ensure all equipment, such as fluorescence detectors, thermostats, and pipettes, are calibrated and functioning correctly. Check that instruments are working properly before use, with no error messages or malfunctions.

Reagents: Store reagents and standard endotoxin solutions at 2–8°C as per instructions. Always use endotoxin-free water when preparing solutions to maintain their purity and effectiveness.

Consumables: Use endotoxin-free pipette tips and glassware during sample preparation to avoid outsourced contamination. Make sure to vortex samples well for consistent mixing.

How to Perform Endotoxin Testing: Key Steps and Controls

• Sample Handling

During sample collection, ensure that all sampling tools are sterile and free from endotoxins. Use single-use, sterile sampling equipment and follow the specified sampling methods to avoid outsourced contamination.

Different sample types require different handling. For liquid samples like injections, use endotoxin-free diluents and follow correct dilution ratios. Solid samples need to be fully dissolved without introducing endotoxin contamination. Test samples as soon as possible to avoid changes in endotoxin levels.

• Reagent Preparation

When preparing the rFC endotoxin assay reagents, follow the manufacturer’s instructions carefully. For standard endotoxin solutions, use stepwise dilution for accuracy. Ensure that pipettes are calibrated for precise liquid handling.

When reconstituting reagents, gently shake the solution (avoid vigorous shaking) and follow the correct temperature and time guidelines. Use the reconstituted reagents immediately to reduce the risk of outsourced contamination.

• Sample Addition and Reaction

Add samples in the correct order to avoid confusion. It’s best to separate samples, standards, and blanks to reduce outsourced contamination. After adding samples, cover the plate and place it in a thermostat at 37°C for the reaction. Avoid opening the thermostat during the reaction to maintain stable conditions.

How to Interpret Endotoxin Test Results: Controls and Acceptance Criteria

Endotoxin results should be reported only after confirming assay validity and evaluating sample suitability.

• Observation Method

The rFC assay uses fluorescence signals to determine the endotoxin levels. During the observation process, it is crucial to ensure that the instrument settings are correct and the test is conducted under proper conditions to maintain signal accuracy and stability.

• Result Analysis and Reporting

According to pharmacopeia guidelines, the interpretation of endotoxin test results must meet three key criteria:

Only when both the first and second conditions are met can the standard curve be considered valid for calculating the endotoxin content in the sample, as well as the total content after spiking. Additionally, if the recovery rate of the spiked samples meets the third condition, the endotoxin test results can be considered acceptable.

If any of the criteria are not met, the test must be repeated.

Regulatory Updates on Recombinant Endotoxin Testing

Regulatory recognition of recombinant endotoxin testing is expanding. FDA guidance and USP ⟨86⟩ address recombinant reagents, including rFC and rCR, while revised Ph. Eur. 2.6.14 is scheduled to recognize rFC as Method G from January 1, 2027. Manufacturers should verify method suitability and follow applicable compendial requirements.

SAFENSURE™ Recombinant Factor C Endotoxin Detection Kit

The SAFENSURE™ Recombinant Factor C Endotoxin Detection Kit (Cat. NO. RES-A056) uses endpoint fluorescence to quantify endotoxins across 0.005–5 EU/mL. Developed using recombinant Factor C (rFC) technology, the assay offers high sensitivity, specificity, and lot-to-lot consistency while avoiding β-glucan-mediated interference associated with certain LAL formats.

To support reliable testing in complex samples, we also provide key ancillary reagents and consumables, including an LER Demasking Buffer designed to mitigate Low Endotoxin Recovery (LER) effects and Endotoxin-Free Glass Test Tubes, helping reduce matrix interference and improve detection reliability.

Validation Data

• High Specificity, effectively eliminates β-glucan interference.

The rFC method was employed to detect endotoxin residues in β-glucan at concentrations of 10ug/mL and 1ug/mL. No non-specific signals were detected. In contrast, the dynamic chromogenic method used for β-glucan detection resulted in the detection of endotoxin and non-specific signals. This indicates that recombinant factor C does not react with β-glucan, demonstrating the good specificity of the rFC method.

• Real Sample Validation, the test results are comparable to the LAL method, demonstrating reliable accuracy.

The kit is applicable in endotoxin detection of injectable drugs and some medium, such as Recombinant Human Interferon α-1b, Human insulin injection and different mediums. The results of the rFc method of this kit are compared with those of LAL method.

Click to Inquire!

Recommended Products

Upcoming Endotoxin Detection Insights Series: